跳至主要内容
临床试验/NCT01503606
NCT01503606已完成3 期

Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane, Phase III Study.

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 151 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
151
试验地点
1
主要终点
Neonatal composite morbidity

研究概览

简要总结

The purpose of this study is to compare the neonatal outcome and infant neurologic outcome whose mother were treated with cefazolin plus clarithromycin for one week or until delivery after preterm premature rupture of membrane.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

性别
Female
接受健康志愿者

入选标准

  • preterm premature rupture of membrane(PPROM), PA 22+0~34+0wks
  • ROM <72 hrs before randomization
  • cervical dilatation <3cm
  • uterine contraction less than 4 times per 1 hr

排除标准

  • Major fetal malformation
  • Rupture of the membrane >72hrs before randomization
  • Vaginal bleeding
  • IIOC (incompetent internal os of cervix)
  • Placenta previa
  • Gestational diabetes or overt diabetes
  • Hypertensive disorders in pregnancy
  • Liver cirrhosis
  • Acute renal failure

研究组 & 干预措施

one-week treatment group

Active Comparator

Cefazolin 1.0gm IVs q 12 hours plus clarithromycin 500mg po bid after randomization for one week

干预措施: Cefazolin (Drug)

one-week treatment group

Active Comparator

Cefazolin 1.0gm IVs q 12 hours plus clarithromycin 500mg po bid after randomization for one week

干预措施: Clarithromycin (Drug)

until-delivery treatment group

Active Comparator

Cefazolin 1.0gm IVs q 12 hours plus clarithromycin 500mg po bid after randomization until delivery

干预措施: Cefazolin (Drug)

until-delivery treatment group

Active Comparator

Cefazolin 1.0gm IVs q 12 hours plus clarithromycin 500mg po bid after randomization until delivery

干预措施: Clarithromycin (Drug)

结局指标

主要结局

Neonatal composite morbidity

时间窗: Participants will be followed for duration of hospital day after delivery, an expected average of 8 weeks

1. respiratory distress syndrome(RDS) 2. bronchopulmonary dysplasia(BPD) 3. intraventricular hemorrhage(IVH,≥grade 3) 4. retinopathy of prematurity(ROP,≥grade 3) 5. necrotizing enterocolitis(NEC,≥stage 2) 6. proven neonatal sepsis

次要结局

  • infantile neurologic outcome(at 6 months and 1 year of corrected age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Oh Soo Young

Associate professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验

Duration of Antibiotics Treatment With Cefazolin and... | 临床试验